AtriCure Inc at Needham Healthcare Conference (Virtual) Transcript
Good afternoon. Thanks for joining us at the 22nd Annual Needham Healthcare Conference. I'm Mike Matson, and I lead the med-tech and diagnostics equity research team at Needham and Company. I'm pleased to introduce AtriCure's CEO, Mike Carrel; and CFO, Angie Wirick.
Instead of a standard presentation, we're going to do a fireside chat or Q&A session. If you have any questions you would like to ask, you can submit them electronically through the Needham website -- sorry, conference website, or feel free to email them to me at [email protected], and I'll do my best to fit them in.
Questions & Answers
So with that, we're just going to move straight into the questions. I guess I'll start with one, just I don't know what you're able to really say about trends in the first quarter.
But given just the spotty procedure growth rates we've seen across the industry quarter to quarter, given staffing and COVID infections and respiratory
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |